Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Psychotic”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Post-approval studies (Phase 4)Ended earlyNCT00418873
What this trial is testing

Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward

Who this might be right for
Schizophrenia
Astellas Pharma Inc 39
Not applicableUnknownNCT03192631
What this trial is testing

Financial Incentives to Improve Acceptance of Antipsychotic Injections

Who this might be right for
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Focus Community Mental Health Team 20
Testing effectiveness (Phase 2)Study completedNCT03510741
What this trial is testing

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder
Pakistan Institute of Living and Learning 64
Testing effectiveness (Phase 2)WithdrawnNCT01272752
What this trial is testing

Anti-psychotic Medication (New Use) Weight Loss Study

Who this might be right for
Obesity
Avera McKennan Hospital & University Health Center
Not applicableWithdrawnNCT02661347
What this trial is testing

Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia

Who this might be right for
SchizophreniaSchizophreniformSchizoaffective Disorder+1 more
Northwell Health
Early research (Phase 1)Study completedNCT04210713
What this trial is testing

Neuroimmune Dysfunction in Alcohol Use Disorder

Who this might be right for
Alcohol DrinkingAlcohol-Related DisordersDisease+13 more
University of Maryland, Baltimore 142
Early research (Phase 1)Study completedNCT00929955
What this trial is testing

Role of Anti-Inflammatory Agents in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychosis Not Otherwise Specified+1 more
Pakistan Institute of Living and Learning 36
Testing effectiveness (Phase 2)Study completedNCT00029458
What this trial is testing

Clozapine for Treatment-Resistant Mania

Who this might be right for
Bipolar Disorder
National Institute of Mental Health (NIMH) 42
Testing effectiveness (Phase 2)Study completedNCT01266174
What this trial is testing

Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults

Who this might be right for
Cognitive ImpairmentSchizophrenia
Amarantus BioScience Holdings, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT00968851
What this trial is testing

Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia

Who this might be right for
SchizophreniaCentral Nervous System DiseasesCognition
FORUM Pharmaceuticals Inc 317
Testing effectiveness (Phase 2)Study completedNCT00206544
What this trial is testing

Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?

Who this might be right for
Bipolar DisorderManiaSchizoaffective Disorder
The Alfred 51
Not applicableUnknownNCT06238089
What this trial is testing

Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales

Who this might be right for
Intellectual Disability
University of Plymouth 600
Post-approval studies (Phase 4)Study completedNCT00044187
What this trial is testing

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Who this might be right for
SchizophreniaPsychotic DisordersBipolar Disorder
Eli Lilly and Company 130
Early research (Phase 1)Study completedNCT00698022
What this trial is testing

A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers

Who this might be right for
Healthy
Corcept Therapeutics 76
Post-approval studies (Phase 4)Ended earlyNCT02343575
What this trial is testing

Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU

Who this might be right for
Hyperactive DeliriumMixed Delirium
Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT01716858
What this trial is testing

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Chiba University 10
Not applicableStudy completedNCT01514682
What this trial is testing

Anti-Inflammatory Treatment of Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 50
Testing effectiveness (Phase 2)Study completedNCT00074477
What this trial is testing

Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 250
Not applicableStudy completedNCT03183609
What this trial is testing

Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)

Who this might be right for
SchizophreniaGluten SensitivitySchizo Affective Disorder
University of Maryland, Baltimore 40
Early research (Phase 1)UnknownNCT02533232
What this trial is testing

Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Pakistan Institute of Living and Learning 60
Load More Results